Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
4
×
boston top stories
clinical trials
life sciences
national blog main
boston
fda
abbvie
access biotechnology
access industries
alexion pharmaceuticals
ally bridge group
amyotrophic lateral sclerosis (als)
anemia
atlas ventures
autoimmune disorders
big data analytics
black diamond therapeutics
blackrock
bladder cancer
blood diseases
blood disorders
blueprint medicines
brian macdonald
cancer
cancer drugs
casdin capital
complement system
deals
deciphera pharmaceuticals
diabetic nephropathy
disc medicine
drug development
eli lilly
elizabeta nemeth
endometral cancer
europe blog main
european society for medical oncology
eventide asset management
What
lead
4
×
drug
medicines
new
biotech
ipo
advance
alternative
analysis
anemia
autoimmune
bio
black
blood
body
bring
cancer
candidate
carry
cells
clinic
companies
company
deal
develop
diamond
disc
disease
diseases
eluded
employing
expensive
genetic
goldfinch
having
health
hopes
iron
kidney
later
Language
unset
Current search:
lead
×
" boston blog main "
×
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Disc Medicine Launches With $50M to Advance New Anemia Treatments
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma